2006 annual financial data
Halozyme Therapeutics 2006 Net margin
Direct answer
Net margin was -1,502.63%.
Operating income was -15,582,856 USD and net income was -14,751,986 USD.
Operating cash flow was 7,079,563 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 981,746 USD
- Operating income
- -15,582,856 USD
- Net income
- -14,751,986 USD
- Operating cash flow
- 7,079,563 USD
Explore related company data
View all 2006 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Halozyme Therapeutics financial years